A Novel Revolutionary Surgical Device for TransOral Incisionless Surgery: EsophyX™ Used for Endoluminal Fundoplication (ELF) in Patients Suffering of Reflux Disease

2009 Advanced Technologies for Enhanced Quality of Life Pub Date : 2009-07-01 DOI:10.1109/AT-EQUAL.2009.13

Adrian Lobontiu, D. Loisance

引用次数: 0

Abstract

The novel Endoluminal Fundoplication (ELF) technique using a Trans-Oral Incisionless and fastener-deploying device (EsophyX™, EndoGastric Solutions) was developed and evaluated for feasibility, safety and the treatment of Gastro-Esophageal Reflux Disease (GERD) in a series of animal and human (phase 1, phase 2) studies.

查看原文本刊更多论文

一种用于经口无切口手术的新型革命性手术设备:EsophyX™用于患有反流疾病的患者的腔内底扩张(ELF)

在一系列动物和人类(1期和2期)研究中，开发并评估了使用经口无切口和固定装置(EsophyX™，EndoGastric Solutions)的新型腔内翻底(ELF)技术的可行性、安全性和对胃食管反流病(GERD)的治疗效果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

2009 Advanced Technologies for Enhanced Quality of Life

自引率

0.00%

发文量